Clinical Trial Update: TRK-100STP PhaseII Clinical Study -Chronic Renal Failure (Primary Glomerular Disease/Nephrosclerosis) [Phase 2]

View source ↗

Summary

A Phase II trial of TRK-100STP for chronic kidney disease due to primary glomerular disease or nephrosclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Glomerulonephritis
• Nephrosclerosis

Drugs mentioned

• TRK-100STP

Snippet

Sponsor: Toray Industries, Inc | Conditions: Renal Insufficiency, Chronic | Phase 2 | Status: COMPLETED